LinkedIn Profile

Access Adamis Pharmaceuticals historical Linkedin company profile data on number of followers, employee headcount and more
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
nasdaq:admp 3713669 Feb 2nd, 2024 12:00AM DMK Pharmaceuticals Corporation 2.3K 16.00 Open Feb 1st, 2024 10:55PM Feb 2nd, 2024 01:49PM DMK Pharmaceuticals (NASDAQ: DMK) is a commercial stage neuro-biotech company primarily focused on developing and commercializing products for the treatment of opioid overdose and substance use disorders.The commercially approved products include ZIMHI® (naloxone) and SYMJEPI®. ZIMHI® (naloxone) Injection is FDA approved for opioid overdose emergency rescue. SYMJEPI® (epinephrine) Injection is FDA approved for use in the emergency treatment of acute allergic reactions, including anaphylaxis. Open Open 11682 El Camino Real, Suite 300 San Diego CA US 92130 Adamis Pharmaceuticals Pharmaceuticals & Biotechnology
nasdaq:admp 3713669 Feb 1st, 2024 12:00AM DMK Pharmaceuticals Corporation 2.3K 16.00 Open Jan 31st, 2024 09:33PM Feb 1st, 2024 10:46AM DMK Pharmaceuticals (NASDAQ: DMK) is a commercial stage neuro-biotech company primarily focused on developing and commercializing products for the treatment of opioid overdose and substance use disorders.The commercially approved products include ZIMHI® (naloxone) and SYMJEPI®. ZIMHI® (naloxone) Injection is FDA approved for opioid overdose emergency rescue. SYMJEPI® (epinephrine) Injection is FDA approved for use in the emergency treatment of acute allergic reactions, including anaphylaxis. Open Open 11682 El Camino Real, Suite 300 San Diego CA US 92130 Adamis Pharmaceuticals Pharmaceuticals & Biotechnology
nasdaq:admp 3713669 Jan 31st, 2024 12:00AM DMK Pharmaceuticals Corporation 2.3K 16.00 Open Jan 30th, 2024 09:38PM Jan 31st, 2024 11:53AM DMK Pharmaceuticals (NASDAQ: DMK) is a commercial stage neuro-biotech company primarily focused on developing and commercializing products for the treatment of opioid overdose and substance use disorders.The commercially approved products include ZIMHI® (naloxone) and SYMJEPI®. ZIMHI® (naloxone) Injection is FDA approved for opioid overdose emergency rescue. SYMJEPI® (epinephrine) Injection is FDA approved for use in the emergency treatment of acute allergic reactions, including anaphylaxis. Open Open 11682 El Camino Real, Suite 300 San Diego CA US 92130 Adamis Pharmaceuticals Pharmaceuticals & Biotechnology
nasdaq:admp 3713669 Jan 30th, 2024 12:00AM DMK Pharmaceuticals Corporation 2.3K 16.00 Open Jan 29th, 2024 09:33PM Jan 30th, 2024 05:46PM DMK Pharmaceuticals (NASDAQ: DMK) is a commercial stage neuro-biotech company primarily focused on developing and commercializing products for the treatment of opioid overdose and substance use disorders.The commercially approved products include ZIMHI® (naloxone) and SYMJEPI®. ZIMHI® (naloxone) Injection is FDA approved for opioid overdose emergency rescue. SYMJEPI® (epinephrine) Injection is FDA approved for use in the emergency treatment of acute allergic reactions, including anaphylaxis. Open Open 11682 El Camino Real, Suite 300 San Diego CA US 92130 Adamis Pharmaceuticals Pharmaceuticals & Biotechnology
nasdaq:admp 3713669 Jan 29th, 2024 12:00AM DMK Pharmaceuticals Corporation 2.3K 16.00 Open Jan 28th, 2024 09:44PM Jan 29th, 2024 11:27AM DMK Pharmaceuticals (NASDAQ: DMK) is a commercial stage neuro-biotech company primarily focused on developing and commercializing products for the treatment of opioid overdose and substance use disorders.The commercially approved products include ZIMHI® (naloxone) and SYMJEPI®. ZIMHI® (naloxone) Injection is FDA approved for opioid overdose emergency rescue. SYMJEPI® (epinephrine) Injection is FDA approved for use in the emergency treatment of acute allergic reactions, including anaphylaxis. Open Open 11682 El Camino Real, Suite 300 San Diego CA US 92130 Adamis Pharmaceuticals Pharmaceuticals & Biotechnology
nasdaq:admp 3713669 Jan 28th, 2024 12:00AM DMK Pharmaceuticals Corporation 2.3K 16.00 Open Jan 27th, 2024 09:42PM Jan 27th, 2024 09:42PM DMK Pharmaceuticals (NASDAQ: DMK) is a commercial stage neuro-biotech company primarily focused on developing and commercializing products for the treatment of opioid overdose and substance use disorders.The commercially approved products include ZIMHI® (naloxone) and SYMJEPI®. ZIMHI® (naloxone) Injection is FDA approved for opioid overdose emergency rescue. SYMJEPI® (epinephrine) Injection is FDA approved for use in the emergency treatment of acute allergic reactions, including anaphylaxis. Open Open 11682 El Camino Real, Suite 300 San Diego CA US 92130 Adamis Pharmaceuticals Pharmaceuticals & Biotechnology
nasdaq:admp 3713669 Jan 27th, 2024 12:00AM DMK Pharmaceuticals Corporation 2.3K 16.00 Open Jan 26th, 2024 09:37PM Jan 27th, 2024 04:39PM DMK Pharmaceuticals (NASDAQ: DMK) is a commercial stage neuro-biotech company primarily focused on developing and commercializing products for the treatment of opioid overdose and substance use disorders.The commercially approved products include ZIMHI® (naloxone) and SYMJEPI®. ZIMHI® (naloxone) Injection is FDA approved for opioid overdose emergency rescue. SYMJEPI® (epinephrine) Injection is FDA approved for use in the emergency treatment of acute allergic reactions, including anaphylaxis. Open Open 11682 El Camino Real, Suite 300 San Diego CA US 92130 Adamis Pharmaceuticals Pharmaceuticals & Biotechnology
nasdaq:admp 3713669 Jan 26th, 2024 12:00AM DMK Pharmaceuticals Corporation 2.3K 16.00 Open Jan 25th, 2024 09:36PM Jan 26th, 2024 04:29PM DMK Pharmaceuticals (NASDAQ: DMK) is a commercial stage neuro-biotech company primarily focused on developing and commercializing products for the treatment of opioid overdose and substance use disorders.The commercially approved products include ZIMHI® (naloxone) and SYMJEPI®. ZIMHI® (naloxone) Injection is FDA approved for opioid overdose emergency rescue. SYMJEPI® (epinephrine) Injection is FDA approved for use in the emergency treatment of acute allergic reactions, including anaphylaxis. Open Open 11682 El Camino Real, Suite 300 San Diego CA US 92130 Adamis Pharmaceuticals Pharmaceuticals & Biotechnology
nasdaq:admp 3713669 Jan 25th, 2024 12:00AM DMK Pharmaceuticals Corporation 2.3K 16.00 Open Jan 24th, 2024 08:04PM Jan 24th, 2024 09:56PM DMK Pharmaceuticals (NASDAQ: DMK) is a commercial stage neuro-biotech company primarily focused on developing and commercializing products for the treatment of opioid overdose and substance use disorders.The commercially approved products include ZIMHI® (naloxone) and SYMJEPI®. ZIMHI® (naloxone) Injection is FDA approved for opioid overdose emergency rescue. SYMJEPI® (epinephrine) Injection is FDA approved for use in the emergency treatment of acute allergic reactions, including anaphylaxis. Open Open 11682 El Camino Real, Suite 300 San Diego CA US 92130 Adamis Pharmaceuticals Pharmaceuticals & Biotechnology
nasdaq:admp 3713669 Jan 24th, 2024 12:00AM DMK Pharmaceuticals Corporation 2.3K 16.00 Open Jan 24th, 2024 05:46AM Jan 24th, 2024 05:46AM DMK Pharmaceuticals (NASDAQ: DMK) is a commercial stage neuro-biotech company primarily focused on developing and commercializing products for the treatment of opioid overdose and substance use disorders.The commercially approved products include ZIMHI® (naloxone) and SYMJEPI®. ZIMHI® (naloxone) Injection is FDA approved for opioid overdose emergency rescue. SYMJEPI® (epinephrine) Injection is FDA approved for use in the emergency treatment of acute allergic reactions, including anaphylaxis. Open Open 11682 El Camino Real, Suite 300 San Diego CA US 92130 Adamis Pharmaceuticals Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.